Results 121 to 130 of about 17,763 (261)

Efficacy of caspofungin dose escalation against Candida albicans and Candida glabrata clinical isolates [PDF]

, 2016
Munkánk során meghatároztuk a caspofungin által kifejtett ölési rátát RPMI-1640-ben, valamint 50% humán szérummal kiegészített tápközegben C. albicans és C. glabrata klinikai izolátumok ellen.
Domán, Marianna
core  

FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure [PDF]

, 2020
Ana P. Silva, Isabel M. Miranda, Joana Branco, Patrícia Oliveira, Isabel Faria‐Ramos, Raquel M. Silva, Acácio G. Rodrigues, Sofia Costa‐de‐Oliveira   +7 more
openalex   +1 more source

Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples [PDF]

, 2018
María Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez‐Carrillo, Emilio Bouza, Patricia Muñóz, Pilar Escribano, Jesús Guinea   +6 more
openalex   +1 more source

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts [PDF]

, 1998
Ana Espinel‐Ingroff
openalex   +1 more source

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris [PDF]

, 2018
Milena Kordalewska, Annie Lee, Steven Park, Indira Berrío, Anuradha Chowdhary, Yanan Zhao, David S. Perlin   +6 more
openalex   +1 more source

P017 Echinocandin resistance mechanism in Candida tropicalis and Candida glabrata [PDF]

, 2022
Dipti Sharma, Raees A. Paul, Jayashree Murlidharan, Sadhna Sharma, Harsimran Kaur, Anup Ghosh, Arunaloke Chakrabarti, Shivaprakash M. Rudramurthy   +7 more
openalex   +1 more source

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia

, 2021
Daiki Sakai, Wataru Matsumiya, Sentaro Kusuhara, Makoto Nakamura   +3 more
openalex   +2 more sources

Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole? [PDF]

, 2017
Audrey Le, Dimitrios Farmakiotis, Jeffrey J. Tarrand, Dimitrios P. Kontoyiannis   +3 more
openalex   +1 more source

Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database

Thrombosis Journal
Background Echinocandins belong to the fourth generation of antifungals, and there are no systematic studies on their risk in coagulation dysfunction; this study will predict the risk of coagulation dysfunction of echinocandins using the US Food and Drug
Qian Cheng, Ye Wu, Zeyu Yao, Mengling Ouyang, Shupeng Zou, Xuan Shi, Yazheng Zhao, Minghui Sun   +7 more
doaj   +1 more source

Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in pbr1 Mutants Resistant to the Glucan Synthesis Antifungals Papulacandins and Echinocandins

, 2019
Rodrigo Berzaghi, Attila Agócs, María Ángeles Curto, Gergely Gulyás‐Fekete, Béla Kocsis, J. Ribas, Tamás Lóránd   +6 more
openalex   +1 more source